Cargando…

Rituximab-related Severe Toxicity

Detalles Bibliográficos
Autores principales:	Ghrenassia, E., Mariotte, E., Azoulay, E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176228/ http://dx.doi.org/10.1007/978-3-319-73670-9_43

Ejemplares similares

Epidemiology, clinical features, and management of severe hypercalcemia in critically ill patients
por: Mousseaux, Cyril, et al.
Publicado: (2019)

Rituximab-Related Pulmonary Toxicity
por: Herishanu, Yair, et al.
Publicado: (2010)

Outcomes in 1096 patients with severe thrombotic thrombocytopenic purpura before the Caplacizumab era
por: Van de Louw, Andry, et al.
Publicado: (2021)

Rituximab for treatment of severe lupus nephritis
por: Baskin, E, et al.
Publicado: (2008)

High-dose methotrexate in ICU patients: a retrospective study
por: Valade, Sandrine, et al.
Publicado: (2020)

FEASIBILITY AND SAFETY OF ACTIVE PHYSIOTHERAPY IN THE INTENSIVE CARE UNIT FOR INTUBATED PATIENTS WITH MALIGNANCY
por: GAUTHERET, N., et al.
Publicado: (2023)

Ocrelizumab/rituximab: Various toxicities: 6 case reports
Publicado: (2021)

Bortezomib/ibrutinib/rituximab: Various toxicities: case report
Publicado: (2021)

Severe CIDP-MGUS responsive to Rituximab
por: Posa, Andreas, et al.
Publicado: (2020)

SEVERE ADENOVIRUS PNEUMONIA IN RITUXIMAB INFUSIONS
por: BJORK, SARAH, et al.
Publicado: (2021)

Development of anti-rituximab antibodies in rituximab-treated patients: Related parameters & consequences
por: Saffari, Fatemeh, et al.
Publicado: (2022)

Renal recovery after severe acute kidney injury in critically ill myeloma patients: a retrospective study
por: Joseph, Adrien, et al.
Publicado: (2018)

Severe Primary Raynaud's Disease Treated with Rituximab
por: Shabrawishi, Mohammed, et al.
Publicado: (2016)

Rituximab in Primary Membranous Nephropathy With Severe CKD
por: Naik, Sachin, et al.
Publicado: (2023)

Demonstration of highly specific toxicity of the α-emitting radioimmunoconjugate(211)At-rituximab against non-Hodgkin's lymphoma cells
por: Aurlien, E, et al.
Publicado: (2000)

Severe Headache in Primary Sjögren’s Syndrome Responded to Rituximab
por: Kudsi, Maysoun, et al.
Publicado: (2023)

Rituximab-Related Reversible Hepatocellular Damage
por: Toprak, Selami K., et al.
Publicado: (2012)

Rituximab
por: Tridente, Giuseppe
Publicado: (2013)

Azathioprine/rituximab: Liver toxicity, myasthenia crisis and COVID-19: case report
Publicado: (2021)

Lactobacillus reuteri Alleviates Gastrointestinal Toxicity of Rituximab by Regulating the Proinflammatory T Cells in vivo
por: Zhao, Binyan, et al.
Publicado: (2021)

Rituximab in severe skin diseases: target, disease, and dose
por: Bennett, Daniel D, et al.
Publicado: (2010)

Rituximab therapy for a severe case of pretibial myxedema
por: Jimenez, Amber, et al.
Publicado: (2021)

Candidemia in critically ill immunocompromised patients: report of a retrospective multicenter cohort study
por: Ghrenassia, Etienne, et al.
Publicado: (2019)

Clinical Warburg effect in lymphoma patients admitted to intensive care unit
por: Chaba, Anis, et al.
Publicado: (2023)

Rituximab in relapsing and de novo MPO ANCA-associated vasculitis with severe renal involvement: a case series
por: Caroti, L., et al.
Publicado: (2019)

Rituximab in Idiopathic Pulmonary Hemosiderosis in Children: A Novel and Less Toxic Treatment Option
por: Terheggen-Lagro, Suzanne W. J., et al.
Publicado: (2022)

Factors Influencing Infusion-Related Reactions Following Dosing of Reference Rituximab and PF-05280586, a Rituximab Biosimilar
por: Courville, Jocelyn, et al.
Publicado: (2021)

Rituximab therapy in steroid-resistant severe hypothyroid Grave's ophthalmopathy
por: Pandit, Aditi, et al.
Publicado: (2013)

Eosinophilic granulomatosis with polyangiitis with severe pulmonary hemorrhage treated with rituximab
por: Baikunje, S., et al.
Publicado: (2016)

Severe headache in primary Sjögren’s syndrome treated with intrathecal rituximab
por: Tjensvoll, Anne Bolette, et al.
Publicado: (2019)

Influence of Gender on Outcome of Severe Sepsis
por: Adrie, C., et al.
Publicado: (2007)

Influence of Gender on Outcome of Severe Sepsis
por: Adrie, C., et al.
Publicado: (2007)

Coagulation disorders in patients with severe hemophagocytic lymphohistiocytosis
por: Valade, Sandrine, et al.
Publicado: (2021)

Molecular targeted therapy-related life-threatening toxicity in patients with malignancies. A systematic review of published cases
por: Assoun, Sandra, et al.
Publicado: (2019)

Successful treatment of IgG4‐related hypertrophic pachymeningitis with induction rituximab and dexamethasone followed by maintenance rituximab
por: Seegobin, Karan, et al.
Publicado: (2021)

Rituximab for refractory granulomatous eye disease
por: Lower, Elyse E, et al.
Publicado: (2012)

Dégradation respiratoire et COVID-19… Et si c’était un pneumomédiastin ?
por: Ghrenassia, Gabriel, et al.
Publicado: (2022)

The effect of Rituximab treatment on T cells
por: Diaz-Torné, C, et al.
Publicado: (2010)

A Case of Autoimmune Hepatitis Treated with Rituximab
por: Barth, E., et al.
Publicado: (2010)

Vasculitic emergencies in the intensive care unit: a special focus on cryoglobulinemic vasculitis
por: Zaidan, Mohamad, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vve40iorj51i24ujvh4jjitil2